Nanostructured lipid matrices for improved microencapsulation of drugs.
about
Nanostructured lipid carriers: An emerging platform for improving oral bioavailability of lipophilic drugsNanostructured lipid carriers: a potential drug carrier for cancer chemotherapySolid lipid nanoparticles: a modern formulation approach in drug delivery system.Opening up the optical imaging window using nano-luciferin.Active Targeting of Sorafenib: Preparation, Characterization, and In Vitro Testing of Drug-Loaded Magnetic Solid Lipid Nanoparticles.Solid lipid nanoparticles bearing oxybenzone: in-vitro and in-vivo evaluation.Vitamin D3-Loaded Nanostructured Lipid Carriers as a Potential Approach for Fortifying Food Beverages; in Vitro and in Vivo Evaluation.Formulation development and in vitro evaluation of didanosine-loaded nanostructured lipid carriers for the potential treatment of AIDS dementia complex.Capsaicin-loaded nanolipoidal carriers for topical application: design, characterization, and in vitro/in vivo evaluation.Nanotechnology applications for the therapy of liver fibrosis.Formulation, characterization and pulmonary deposition of nebulized celecoxib encapsulated nanostructured lipid carriers.Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinicSolid lipid nanoparticles for ocular drug delivery.Characterization and in vivo evaluation of novel lipid-chlorambucil nanospheres prepared using a mixture of emulsifiers for parenteral administrationFormulation of a novel oxybenzone-loaded nanostructured lipid carriers (NLCs)Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery.Nanostructured lipid carriers for percutaneous administration of alkaloids isolated from Aconitum sinomontanumLipid based particulate formulations for the delivery of antigen.Improvement of oral bioavailability of lovastatin by using nanostructured lipid carriers.Effect of solid lipid's structure on nanostructured lipid carriers encapsulated with sun filter: characterisation, photo-stability and in vitro release.A critical review of lipid-based nanoparticles for taxane delivery.Liquid crystal nanoparticle formulation as an oral drug delivery system for liver-specific distributionNanoscale Delivery of Resveratrol towards Enhancement of Supplements and NutraceuticalsEmerging nanomedicine opportunities with perfluorocarbon nanoparticles.Nanostructured lipid carriers for oral bioavailability enhancement of raloxifene: Design and in vivo study.Sustained-release genistein from nanostructured lipid carrier suppresses human lens epithelial cell growthImportance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives.Anthracycline Nano-Delivery Systems to Overcome Multiple Drug Resistance: A Comprehensive Review.Potential advantages of a novel chitosan-N-acetylcysteine surface modified nanostructured lipid carrier on the performance of ophthalmic delivery of curcumin.Lipid-based colloidal carriers for peptide and protein delivery--liposomes versus lipid nanoparticles.Advanced drug delivery to the lymphatic system: lipid-based nanoformulations.Nanomedicine for uterine leiomyoma therapyPreparation, characterization, and in vivo pharmacokinetics of nanostructured lipid carriers loaded with oleanolic acid and gentiopicrin.Synergistic and complete reversal of the multidrug resistance of mitoxantrone hydrochloride by three-in-one multifunctional lipid-sodium glycocholate nanocarriers based on simultaneous BCRP and Bcl-2 inhibition.Nanomedicine engulfed by macrophages for targeted tumor therapyNovel sulpiride-loaded solid lipid nanoparticles with enhanced intestinal permeabilityNanostructured lipid carriers as a novel oral delivery system for triptolide: induced changes in pharmacokinetics profile associated with reduced toxicity in male rats.Nanostructured lipid carriers for incorporation of copper(II) complexes to be used against Mycobacterium tuberculosisFeasibility of lipid nanoparticles for ocular delivery of anti-inflammatory drugs.The value of tocotrienols in the prevention and treatment of cancer.
P2860
Q26774831-5CDF0D97-6068-4CDE-A1C8-E4D5D38A52F2Q27027328-0F9DAF87-5D4D-4585-A363-DC8305588260Q30481400-9E1F872A-BB2A-44B0-BB7E-A2A44BBF1DF1Q30596619-6FD151D5-DB73-458E-9858-F2DCC0FB66B1Q30964683-394D75FE-461F-4162-B12F-E2339656F7E5Q33484906-7BED9E47-920E-429A-A045-94B2F56D3F71Q33664092-D2DD4661-918D-4146-9D12-475D92E30C1AQ33710923-1C54BDA5-180E-4955-9234-DB559F97FB96Q33734460-DAD41FEA-6ACC-4004-B85C-75AF44A21DE9Q33780124-3BB5FF3A-0F17-40A5-9D10-CBF49AE3E052Q33846935-8F2CC30F-B48F-47AB-836D-DEEF11286B1BQ33911056-78404E00-3BAC-43F3-A423-F22C3B032126Q34116807-1D335287-F94C-44F2-8C6F-179973E13E9AQ34440034-A45B105C-1969-482B-8AF4-4F0DC997741FQ34444568-6DAE2B69-689E-40E0-86F0-FECD98E365A6Q34733880-385B3DDD-7B69-4F37-B3B6-06869D7F8D9DQ35686436-A5022A7B-4791-4BDD-B6FE-F3EC5EFDD93CQ36062119-5BC0C0DB-34D4-4976-BFD6-E6288B0099FFQ36093269-3A44AFF0-633B-4ED6-BFB9-F64B110F29DDQ36268101-4DEE9F91-FAD6-4505-8FDC-A0DBD6DA6324Q36360764-CDE02398-79F1-49F9-BE93-4C266D5A9236Q36659315-1F45F52D-3241-48C0-9806-97A1B1F95813Q36732033-003030D9-0147-4995-9CAD-160858142DFFQ36759502-97C9B37F-8B4F-4D04-86C5-20E5BFA208C6Q36870135-BF713942-1A2F-48ED-B459-21797F4C2839Q36951125-683E0739-6489-407C-B681-F7CD2FCBABF1Q37004099-068B7CBC-1B9F-4CC9-9831-23E8243B78D1Q37031597-2459A97F-3C6B-477D-8DA1-9740AEEAB0AEQ37044440-814AB42E-153C-4C31-AB73-01422181BDFEQ37059900-517D779A-E2B8-4269-ADA9-2507BEE604FFQ37066550-357FFB06-7B53-4A94-B974-262D2DA29957Q37124426-DF80E2D8-0E25-4F8C-A8A3-56B34D7771BCQ37134733-51AB1B6F-8D9B-4333-93AB-7EB69B16CA5BQ37214483-B3320D57-98FE-449E-8E8B-06C8A8D7B75EQ37214494-D110AA82-7942-47A0-86B6-A87129D4399FQ37412657-FA82F2A4-09B5-40AA-B3DC-42D97B620377Q37602960-4ED83547-779A-406B-BC97-D1223358C6A5Q37722890-70B473D7-371A-403D-B58A-4E60DBC50FF3Q37769529-B5A502DE-EC53-4602-BC0D-7B737DB2599CQ37786154-FC847B94-46FC-46FC-B817-2BBF0EA24A9B
P2860
Nanostructured lipid matrices for improved microencapsulation of drugs.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Nanostructured lipid matrices for improved microencapsulation of drugs.
@en
Nanostructured lipid matrices for improved microencapsulation of drugs.
@nl
type
label
Nanostructured lipid matrices for improved microencapsulation of drugs.
@en
Nanostructured lipid matrices for improved microencapsulation of drugs.
@nl
prefLabel
Nanostructured lipid matrices for improved microencapsulation of drugs.
@en
Nanostructured lipid matrices for improved microencapsulation of drugs.
@nl
P2093
P1476
Nanostructured lipid matrices for improved microencapsulation of drugs.
@en
P2093
P304
P356
10.1016/S0378-5173(02)00180-1
P407
P577
2002-08-01T00:00:00Z